Reflect Scientific, Inc. (RSCF)
USD 0.04
(-3.26%)
USD 0.04
(-3.26%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -1.03 Million USD | 21.84% |
| 2022 | -1.32 Million USD | 2.61% |
| 2021 | -1.36 Million USD | -274.49% |
| 2020 | -363.18 Thousand USD | 25.51% |
| 2019 | -487.55 Thousand USD | -131.56% |
| 2018 | -210.54 Thousand USD | 10.73% |
| 2017 | -235.85 Thousand USD | 10.65% |
| 2016 | -263.96 Thousand USD | 6.62% |
| 2015 | -282.69 Thousand USD | -170.81% |
| 2014 | 399.22 Thousand USD | -21.58% |
| 2013 | 509.06 Thousand USD | 9.68% |
| 2012 | 464.13 Thousand USD | -82.73% |
| 2011 | 2.68 Million USD | -4.62% |
| 2010 | 2.81 Million USD | -3.49% |
| 2009 | 2.92 Million USD | 96.36% |
| 2008 | 1.48 Million USD | 553.81% |
| 2007 | -327.71 Thousand USD | -71.6% |
| 2006 | -190.97 Thousand USD | 61.19% |
| 2005 | -492.1 Thousand USD | -361.34% |
| 2004 | 188.29 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -780.75 Thousand USD | 24.59% |
| 2024 Q2 | -888.92 Thousand USD | -13.85% |
| 2023 FY | -1.03 Million USD | 21.84% |
| 2023 Q4 | -1.03 Million USD | 4.65% |
| 2023 Q3 | -1.08 Million USD | 21.43% |
| 2023 Q1 | -1.15 Million USD | 12.66% |
| 2023 Q2 | -1.38 Million USD | -19.47% |
| 2022 Q3 | -1.25 Million USD | -7.86% |
| 2022 Q1 | -1.47 Million USD | -8.76% |
| 2022 Q4 | -1.32 Million USD | -5.74% |
| 2022 FY | -1.32 Million USD | 2.61% |
| 2022 Q2 | -1.16 Million USD | 21.49% |
| 2021 Q2 | -917.92 Thousand USD | -21.94% |
| 2021 Q1 | -752.76 Thousand USD | -107.27% |
| 2021 FY | -1.36 Million USD | -274.49% |
| 2021 Q4 | -1.36 Million USD | -33.73% |
| 2021 Q3 | -1.01 Million USD | -10.8% |
| 2020 FY | -363.18 Thousand USD | 25.51% |
| 2020 Q1 | 555.15 Thousand USD | 213.87% |
| 2020 Q4 | -363.18 Thousand USD | 0.0% |
| 2019 Q4 | -487.55 Thousand USD | -26.16% |
| 2019 FY | -487.55 Thousand USD | -131.56% |
| 2019 Q3 | -386.44 Thousand USD | -210.0% |
| 2019 Q2 | -124.65 Thousand USD | 22.93% |
| 2019 Q1 | -161.75 Thousand USD | 23.18% |
| 2018 Q3 | -168.48 Thousand USD | -17.26% |
| 2018 Q4 | -210.54 Thousand USD | -24.96% |
| 2018 FY | -210.54 Thousand USD | 10.73% |
| 2018 Q1 | -242.67 Thousand USD | -2.89% |
| 2018 Q2 | -143.68 Thousand USD | 40.79% |
| 2017 FY | -235.85 Thousand USD | 10.65% |
| 2017 Q2 | -175.51 Thousand USD | 24.86% |
| 2017 Q1 | -233.58 Thousand USD | 11.51% |
| 2017 Q4 | -235.85 Thousand USD | -34.5% |
| 2017 Q3 | -175.35 Thousand USD | 0.09% |
| 2016 FY | -263.96 Thousand USD | 6.62% |
| 2016 Q4 | -263.96 Thousand USD | 16.16% |
| 2016 Q2 | -234.1 Thousand USD | -33.34% |
| 2016 Q1 | -175.57 Thousand USD | 37.89% |
| 2016 Q3 | -314.83 Thousand USD | -34.49% |
| 2015 Q4 | -282.69 Thousand USD | 14.29% |
| 2015 FY | -282.69 Thousand USD | -170.81% |
| 2015 Q3 | -329.83 Thousand USD | -11.91% |
| 2015 Q2 | -294.74 Thousand USD | -197.26% |
| 2015 Q1 | 303.04 Thousand USD | -24.09% |
| 2014 Q4 | 399.22 Thousand USD | -5.88% |
| 2014 Q3 | 424.14 Thousand USD | 9.19% |
| 2014 FY | 399.22 Thousand USD | -21.58% |
| 2014 Q2 | 388.45 Thousand USD | -9.91% |
| 2014 Q1 | 431.16 Thousand USD | -15.3% |
| 2013 FY | 509.06 Thousand USD | 9.68% |
| 2013 Q4 | 509.06 Thousand USD | -0.29% |
| 2013 Q3 | 510.54 Thousand USD | 0.43% |
| 2013 Q2 | 508.37 Thousand USD | -5.08% |
| 2013 Q1 | 535.58 Thousand USD | 15.39% |
| 2012 FY | 464.13 Thousand USD | -82.73% |
| 2012 Q2 | 2.74 Million USD | -2.16% |
| 2012 Q1 | 2.8 Million USD | 4.46% |
| 2012 Q3 | 538.04 Thousand USD | -80.41% |
| 2012 Q4 | 464.13 Thousand USD | -13.74% |
| 2011 Q1 | 2.78 Million USD | -1.06% |
| 2011 Q3 | 2.71 Million USD | -3.52% |
| 2011 Q2 | 2.81 Million USD | 0.94% |
| 2011 FY | 2.68 Million USD | -4.62% |
| 2011 Q4 | 2.68 Million USD | -1.01% |
| 2010 Q1 | 2.99 Million USD | 2.63% |
| 2010 Q4 | 2.81 Million USD | -4.44% |
| 2010 FY | 2.81 Million USD | -3.49% |
| 2010 Q3 | 2.94 Million USD | 0.05% |
| 2010 Q2 | 2.94 Million USD | -1.65% |
| 2009 Q3 | 2.98 Million USD | 3.31% |
| 2009 Q2 | 2.89 Million USD | 44.74% |
| 2009 Q1 | 1.99 Million USD | 34.4% |
| 2009 FY | 2.92 Million USD | 96.36% |
| 2009 Q4 | 2.92 Million USD | -2.28% |
| 2008 FY | 1.48 Million USD | 553.81% |
| 2008 Q3 | -428.43 Thousand USD | -191.5% |
| 2008 Q2 | 468.21 Thousand USD | 4188.9% |
| 2008 Q1 | 10.91 Thousand USD | 103.33% |
| 2008 Q4 | 1.48 Million USD | 447.13% |
| 2007 Q2 | -1.63 Million USD | -1725.68% |
| 2007 Q4 | -327.71 Thousand USD | 64.79% |
| 2007 FY | -327.71 Thousand USD | -71.6% |
| 2007 Q3 | -930.74 Thousand USD | 43.21% |
| 2007 Q1 | -89.76 Thousand USD | 53.0% |
| 2006 Q2 | 108.18 Thousand USD | 117.56% |
| 2006 Q3 | 190.11 Thousand USD | 75.73% |
| 2006 Q4 | -190.97 Thousand USD | -200.46% |
| 2006 Q1 | -616.09 Thousand USD | -25.2% |
| 2006 FY | -190.97 Thousand USD | 61.19% |
| 2005 FY | -492.1 Thousand USD | -361.34% |
| 2005 Q3 | -461.58 Thousand USD | -9.33% |
| 2005 Q1 | -227.66 Thousand USD | 0.0% |
| 2005 Q4 | -492.1 Thousand USD | -6.61% |
| 2005 Q2 | -422.18 Thousand USD | -85.44% |
| 2004 FY | 188.29 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| American Medical Technologies Inc. | 479.63 Thousand USD | 315.855% |
| Ansell Limited | -54.99 Million USD | 98.118% |
| Ansell Limited | -55.1 Million USD | 98.121% |
| BG Medicine, Inc. | - USD | Infinity% |
| Biotage AB (publ) | -36.49 Million USD | 97.163% |
| BioLife Sciences Inc. | - USD | Infinity% |
| CB Scientific, Inc. | -105.1 Thousand USD | -885.05% |
| Psykey, Inc. | 634.59 Thousand USD | 263.145% |
| ConvaTec Group Plc | 1.2 Billion USD | 100.086% |
| ConvaTec Group Plc | 1.2 Billion USD | 100.086% |
| Encision Inc. | 1.29 Million USD | 180.213% |
| Golden Valley Development, Inc | - USD | Infinity% |
| Hear AtLast Holdings, Inc. | 2.3 Million USD | 144.843% |
| Innovative MedTech Inc. | 1.76 Million USD | 158.666% |
| LifePoint, Inc. | -3.26 Million USD | 68.281% |
| Medite Cancer Diagnostics, Inc. | 4.9 Million USD | 121.111% |
| Paradigm Medical Industries, Inc. | 2.16 Million USD | 147.887% |
| QuantRx Biomedical Corporation | - USD | Infinity% |
| Remedent, Inc. | -43.3 Thousand USD | -2290.788% |
| SmileDirectClub, Inc. | 778.67 Million USD | 100.133% |
| Sector 10, Inc. | 163 Thousand USD | 735.158% |
| Shandong Weigao Group Medical Polymer Company Limited | -417.55 Million USD | 99.752% |
| SheerVision, Inc. | 57.34 Thousand USD | 1905.275% |
| United Health Products, Inc. | 660.56 Thousand USD | 256.73% |
| Vasamed, Inc. | 22.12 Thousand USD | 4779.988% |
| Wearable Health Solutions, Inc. | 2.63 Million USD | 139.347% |
| Yubo International Biotech Limited | 772.27 Thousand USD | 234.059% |